MedTrace Logo

Exhaled Breath Metabolomic Biomarkers in the Acutely Breathless Patient

NCT03672994 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 650

Last updated 2020-01-30

No results posted yet for this study

Summary

An acute study carried out across three acute admissions units within Leicestershire. The study is aimed at discovery and validation of volatile organic compounds (VOCs) in exhaled breath. Participants will be recruited and tested within 24 hours of admission and once recovered, up to 6 months following discharge.

Conditions

Sponsors & Collaborators

  • Medical Research Council

    collaborator OTHER_GOV

  • Engineering and Physical Sciences Research Council, UK

    collaborator OTHER

  • Loughborough University

    collaborator OTHER

  • University Hospitals, Leicester

    collaborator OTHER

  • Owlstone Ltd

    collaborator INDUSTRY

  • B & S ANALYTIK GmbH

    collaborator UNKNOWN

  • Advion Biosciences Ltd

    collaborator UNKNOWN

  • University of Leicester

    lead OTHER

Principal Investigators

  • Salman Siddiqui, Professor · University of Leicester

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-02
Primary Completion
2018-12-30
Completion
2019-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03672994 on ClinicalTrials.gov